Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck’s Fosamax on Trial Again After First Case Halted
Bloomberg
Thursday, April 4, 2013 - 9:14am
tags:
Merck, Fosamax, osteoporosis
Celgene's Rich Pipeline Offers Growth
Seeking Alpha
Thursday, April 4, 2013 - 9:13am
tags:
Celgene, Eli Lilly, Bristol-Myers Squibb, Roche, ONYX Pharmaceuticals, Pomalyst, Revlimid, Abraxane
The Survey Says: Ariad's Leukemia Drug Is Toxic
TheStreet.com
Wednesday, April 3, 2013 - 2:36pm
tags:
Ariad Pharmaceuticals, CML, Iclusig
J&J, Pfizer chip in on $18M round for anti-inflammatory biotech's PhII
Fierce Biotech
Wednesday, April 3, 2013 - 11:39am
tags:
Pfizer, JNJ, asthma, AQX-1125, Aquinox Pharmaceuticals
US holds back on pharma IP in Asia-Pacific trade talks
Pharma Times, UK
Wednesday, April 3, 2013 - 11:36am
tags:
intellectual property, PhRMA
FDA OKs Medtronic's artificial lung system for patients undergoing heart surgery
Yahoo/AP
Wednesday, April 3, 2013 - 11:33am
tags:
FDA, medronic, devices, artificial lung, Affinity Fusion
Pharma DTC ad spending sinks 11.5%, a $2B slide from 2006 peak
Fierce Pharma
Wednesday, April 3, 2013 - 11:31am
tags:
DTC
ViroPharma: Generic Concerns Overblown, Pipeline Will Bring Revenue Diversity
Seeking Alpha
Wednesday, April 3, 2013 - 10:55am
tags:
ViroPharma, Dyax, Shire, Halozyme, generics
Repligen Promises To Be A Cash Flow Machine
Seeking Alpha
Wednesday, April 3, 2013 - 10:53am
tags:
Repligen
Elan completes sale of Tysabri stake to Biogen
Reuters
Wednesday, April 3, 2013 - 10:51am
tags:
Tysabri, Elan, Biogen Idec, MS, multiple sclerosis
Why Anacor Is Poised to Pull Back
Motley Fool
Wednesday, April 3, 2013 - 10:50am
tags:
Anacor
A Clouded Future For Big Pharma's Blockbuster Diabetes Drugs
Seeking Alpha
Wednesday, April 3, 2013 - 10:48am
tags:
diabetes, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Novo Nordisk, Merck, Incretin
Biosimilars Could Be An Unlikely Boost For Pfizer
Seeking Alpha
Wednesday, April 3, 2013 - 10:46am
tags:
biosimilars, Pfizer, trastuzumab, Apixaban, tofacitinib
Pfizer, Novartis, Abbott weigh bids for Brazil's Ache - sources
Reuters
Wednesday, April 3, 2013 - 9:48am
tags:
Pfizer, Novartis, Brazil, Abbott Labs, Ache Laboratorios Farmaceuticos, M&A
Does The World Want, Much Less Need, A New Erectile Dysfunction Drug?
Forbes
Wednesday, April 3, 2013 - 9:46am
tags:
Avanafil, erectile dysfunction, Vivus, Stendra
Zalicus: Renewing Partnership With Novartis Will Be Vital For 2013 Revenues
Seeking Alpha
Wednesday, April 3, 2013 - 9:41am
tags:
Novartis, Zalicus, Z160
Valeant sweetens bid for Obagi Medical
Reuters
Wednesday, April 3, 2013 - 8:46am
tags:
Obagi Medical Products, Valeant Pharmaceuticals, M&A, Merz
Drugmakers to Benefit From Obama's Brain Initiative
Bloomberg
Wednesday, April 3, 2013 - 8:45am
tags:
Obama, brain research, Pfizer, Roche, Eli Lilly
Pfizer to Pay Bind Up to $210 Million in Nanotechnology Deal
Bloomberg
Wednesday, April 3, 2013 - 8:40am
tags:
Nanotechnoogy, Pfizer, Bind Therapeutics
U.S. trade office reviewing India's Supreme Court drug ruling
Reuters
Wednesday, April 3, 2013 - 8:39am
tags:
Novartis, Glivec, patents, India

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.